Recognize and Capture Opportunity in the Extraordinary
Outliers are rare and exceptional. Their vast expense is disproportionate to incidence. Cost of treatment is high and multiplying as more people survive the unsurvivable, thanks to medical innovation and improvements in therapeutic technologies and techniques.
How can you recognize these trends and capture their potential to create brilliant strategy? Join this exciting event for insights to help you identify and seize opportunity in the extraordinary.
Paradigm Outcomes’ eighth annual Innovation Symposium will explore the fascinating realm of outliers and medical innovation. Luminaries in healthcare and science will explore success in the unpredictable and share discoveries as we look to the future.
This private event will feature:
- Expert speakers on medical innovation.
- Thought-provoking discussion to help you see promise amid impossibility
- Opportunities to connect with industry colleagues
- World-class accommodations at the Park Hyatt Chicago on the Magnificent Mile
Experts in critical care, acute rehabilitation and traumatic brain injury will explore the possibilities in the realm of the exceptional.
Gold Medal Paralympic athlete
First person in history to compete in the NCAA as an amputee
Photo Credit: Kenneth Willardt for L'Oreal
Aimée currently appears in the hugely successful Netflix series, Stranger Things. She also has acted in a variety of film and television roles. Her film debut was a starring role in the highly acclaimed film Cremaster 3, by contemporary artist Matthew Barney.
Aimée first received worldwide media attention as an athlete. Born without fibulae in both legs, Aimée’s medical prognosis was discouraging; she was told she would never walk and would likely spend the rest of her life using a wheelchair. In an attempt for an outside chance at independent mobility, doctors amputated both her legs below the knee on her first birthday. The decision paid off. By age two, she had learned to walk on prosthetic legs, and spent her childhood swimming, biking, skiing, playing softball and soccer with everyone else.
After graduating high school with honors, Aimée was one of three students in the US chosen for a full academic scholarship from the Department of Defense, and at age 17 became the youngest person to hold a top-secret security clearance at the Pentagon, where she worked as an intelligence analyst.
While a Dean’s list student at the prestigious School of Foreign Service at Georgetown University, she set her sights on making the U.S. team for the 1996 Atlanta Games. She enlisted the expertise of Frank Gagliano, one of the country’s most respected track coaches. Through this partnership, she became the first woman with a “disability” to compete in the NCAA, doing so on Georgetown’s nationally-ranked Division I track team.
Aimée set her sights on becoming the fastest woman in the world on prosthetic legs, and began to wonder why legs made for sprinting wouldn’t be modeled on those of the fastest land animal, rather than just those of a human. Working in collaboration with a cutting-edge biomedical engineer and a visionary prosthetist, she went on to set world records in the 100 meter, the 200 meter, and the long jump, outfitted with woven carbon-fiber prostheses that were modeled after the hind legs of a cheetah.
These legs, which Aimée was the first to wear, are now the international standard for amputee runners.
Ashish C. Bhatia, MD
Northwestern University associate professor
Founder, Department of Clinical Research at DuPage Medical Group
Dr. Bhatia is an internationally recognized expert in healthcare innovation, involved in the inception and development of numerous drugs and devices that have come to market over the last decade. He works with bioengineers, science researchers, and innovators in pharmaceutical and device research to apply the latest technologies to improve the lives of patients.
Recent innovations that have come to market include lasers that remodel scars to improve both functional and aesthetic outcomes, devices and injections that dissolve fat, and devices used for autologous regeneration of tissue and skin repigmentation with numerous applications including burns, trauma, and post surgical reconstruction.
He founded the Department of Clinical Research at DuPage Medical Group, a 600+ physician group where he oversaw research in over 15 specialties; as well as the DuPage Medical Group Charitable Fund serving the healthcare, food, and shelter needs of the community.
He is passionate about combining his foundation in science with his knowledge of product development to bring transformative discoveries to market. He serves as an advisor to many major technology companies in healthcare, and is a board member of BioMarck Pharmaceuticals, which is investigating a platform of novel proteins for the treatment of acute respiratory distress syndrome (ARDS) and acute lung injury, several cancers in adults and children, as well as numerous dermatologic disorders.
Dr. Bhatia is a board certified dermatologist with fellowship training and subspecialization in dermatologic surgery and cosmetic surgery. His clinical expertise includes Mohs and reconstructive facial surgery, skin cancer therapy and prevention, laser surgery, skin resurfacing procedures, and cosmetic and restorative procedures for adults and children with surgical or traumatic scarring.
He has published extensively in journals and textbooks, and is a teacher, speaker, and instructor both nationally and internationally. He serves on the board of directors of the American Society for Dermatologic Surgery and the American Society of Lasers in Medicine and Surgery. He is also on the editorial board of JAMA Dermatology and serves as the web editor of that journal.
Dr. Bhatia received his medical degree from Northeastern Ohio University College of Medicine, where he was inducted into the Alpha Omega Alpha national medical honors society and earned awards for both achievement and service. He completed his residency in Dermatology at the Medical College of Virginia Hospitals, where he served as Chief Resident. Subsequently, he completed an intensive fellowship in Mohs Surgery, Cutaneous Oncology, Reconstruction, Cosmetic and Laser Surgery at SkinCare Physicians in Boston under the direction of the leaders in the field from Boston University, Harvard University, and Yale University School of Medicine.
Dr. Bhatia is an Associate Professor of Clinical Dermatology at Northwestern University, Feinberg School of Medicine. Dr. Bhatia remains active with the American Academy of Dermatology, American Society for Dermatologic Surgery, the American Society for Laser Medicine and Surgery, the American College of Mohs Surgery, and the American Medical Association.
Geoffrey Ling, MD, PhD
Founding director of the biological technologies office at DARPA
Dr. Geoffrey Ling is a professor of neurology at both Johns Hopkins University and the Uniformed Services University of the Health Sciences, attending neuro critical care physician at Johns Hopkins Hospital, and acting Vice-Chair for Research in the Department of Clinical Neurosciences at Inova Fairfax Hospital.
He is a partner at Sun-Q, LLC, a biotech consulting group, co-founder of On Demand Pharmaceuticals, Inc., which is developing generic medication manufacturing technology with the goal of providing affordable medications to everyone, everywhere, and co-founder of Host Response, an early stage start-up commercializing host biomarkers for identification of infectious disease states.
He serves on the Facebook B8 advisory board, the NIH-NCATS Advisory Council, the World Economic Forum’s Brain Health Committee, the NFL Health Foundation’s Board of Directors, the NFL Players Associations’ Mackey-White Health Committee, and as a scientific advisor to the Caivis Fund.
He was the Founding Director of the Biological Technologies Office at the Defense Advanced Research Projects Agency (DARPA), and served as the Assistant Director for Medical Innovation in President Obama’s White House Office of Science, Technology and Policy (OSTP).
Dr. Ling is a retired U.S. Army colonel having served for 21 years on active duty. As a critical care physician, he was deployed to Afghanistan in 2003 and Iraq in 2005. He also had four in-theater missions between 2009-2011 as a member of the Joint Chiefs of Staff “Gray Team” to assess traumatic brain injury (TBI) care in the combat theater. The 10th Combat Support Hospital named him their first “Physician of the Month.” Dr. Ling was also a “requested by name” consultant to Congresswoman Gabby Gifford’s trauma team following her tragic attack.
Dr. Ling received a BA in Biology and History from Washington University in St. Louis, his medical degree from Georgetown University, and a Ph.D. in neuropharmacology from Cornell University. He is board certified in both neurology and neuro critical care.
Dr. Ling has published more than 200 peer-reviewed primary research journal articles, review articles, and book chapters. His basic scientific works are on mechanisms underlying TBI and opioid pharmacology. His clinical works are on neuro critical care, stroke, and military medicine, including being a contributing author or editor of the Guidelines for the Field Management of Combat Related Head Trauma, the VA-DoD Clinical Practice Guidelines for Mild Traumatic Brain Injury and Concussion, and the chapter on traumatic brain and spinal cord injury in Cecil’s Textbook of Medicine. He is a member of the honor societies of Alpha Omega Alpha, Sigma Xi, and Military Medical Order of Merit. He is a fellow of the American Neurological Association, American Association of Neurology, and the Neurocritical Care Society.
Gary Ulicny, PhD
Former president and CEO of Shepherd Center
Dr. Ulicny has been involved in medical administration for over 30 years. Dr. Ulicny is currently the President and CEO of GRU Health Care, an international consulting group specializing in building business and treatment cultures that promote excellence. For almost 23 years, he served as the President and CEO of Shepherd Center in Atlanta, Georgia, a 152-bed hospital that specializes in the treatment of persons with spinal cord injuries, brain injuries, and other neuromuscular disorders. During Dr. Ulicny’s tenure, Shepherd Center has for 14 years been ranked in US News & World Report as one of the best rehabilitation hospitals in the nation, been presented with the Edward Loveland Award for Distinguished Contributions in Healthcare by the American College of Physicians, selected as the Hospital of The Year by the Georgia Alliance of Hospitals, and named one of Atlanta’s Best Employers by the Atlanta Business Chronicle, and Atlanta magazine. In addition, Shepherd Center has enjoyed model systems designation, both for spinal cord and brain injuries by the National Institute on Disability, Rehabilitation and Research. Dr. Ulicny received the Atlanta Business Chronicle’s Lifetime Achievement Award for contributions to healthcare and was elected as a Fellow of the American Congress of Rehabilitation Medicine.
He received his Ph.D. in behavioral psychology from the University of Kansas in 1986. He is published extensively in the area of rehabilitation and has held adjunct appointments in the School of Medicine at the University of North Carolina-Chapel Hill and in the Department of Human Development at the University of Kansas.
Dr. Ulicny is a member of numerous professional organizations, served on the national board of the Head Injury Foundation and served as the President of the American Congress of Rehabilitation Medicine Dr. Ulicny and his wife Jane have two sons.
Tuesday, September 19
Embracing Adversity – The Life of an Outlier
Aimée Mullins, Paralympian, Actor & Fashion Model
As the pace of business accelerates and established industries spin off, evolve or die, executives face a world far more complex than that of even a decade ago. Competition, technology, paradigm shifts and globalization make outlier cases more and more frequent, resulting in a “crisis as usual” mindset. So how can challenges be addressed in new ways? How can adverse conditions be viewed with curiosity and wonder? Is it possible for your business to thrive when your industry is in survival mode?
Aimée Mullins will share how she answers these questions and how every individual can adopt the mindset that adversity and change are not to be dreaded, but actually welcomed as exciting parts of today’s new normal. From this vantage point, Aimée will impart how she creates her path to success by taking the audience on a journey through some of the critical decision points she has faced in her life — a life that has seen experiences at the Pentagon, the Olympics, in business, acting, modeling and as the president of the Women’s Sports Foundation. Most importantly, through Aimée’s experiences, listeners will see their personal and professional challenges through a powerful new lens and learn to respond in even more authentic, effective and meaningful ways.
Wednesday, September 20
Welcome and Preliminary Actuarial Study Results
Jim Hudak, Chairman and CEO, Paradigm Outcomes
Brian Ingle, Executive Vice President, Willis Towers Watson
Paradigm and a number of leading workers’ compensation insurers are viewing outlier cases in a new light. We present preliminary results of a broad retrospective study on the frequency, reserve development, and drivers of outlier claims.
Searching for a Pound of Cure and Finding an Ounce of Prevention for Chronic Lung Injuries
Dr. Ashish Bhatia, Founder, Department of Clinical Research at DuPage Medical Group
Learn how curiosity and collaboration propel the discovery of groundbreaking therapies to prevent Acute Respiratory Distress Syndrome (ARDS), which typically occurs in the catastrophically injured.
Centers of Excellence: Innovations in Post-Acute Care
Gary Ulicny, PhD, President/CEO, GRU Health Care, Former President/CEO, Shepherd Center
From post-acute care and inpatient settings to outpatient, residential and lifelong support, brain and spinal cord injury patients benefit from ongoing research, innovative technology and specialized rehabilitation protocols.
Brain-Machine Interface and Beyond
Dr. Geoffrey Ling, Professor of Neurology, Johns Hopkins University and the Uniformed Services University of the Health Sciences
Diagnostics and therapeutic responses for brain and spinal cord injury, many pioneered by the Biological Technologies Office at the Defense Advanced Research Projects Agency (DARPA), are creating amazing opportunities for brain injured patients. Research and experience bring the possibilities of human augmentation and restoration to life.
Recap and Thank You
Jim Hudak, Chairman and CEO, Paradigm Outcomes
If you have any questions regarding the Innovation Symposium, please contact your Paradigm representative or the Paradigm marketing team by dialing (925) 677-4934 or sending an email.
1277 Treat Boulevard, Suite 800, Walnut Creek, CA 94597
Phone: (800) 676-6777 | Fax: (925) 680-4469
Paradigm Outcomes provides acute and ongoing case management services for people with acquired brain injuries, spinal cord injuries, multiple traumas, amputations, burns and chronic pain. As the nation’s leading provider of complex and catastrophic medical management in the workers’ compensation industry, Paradigm achieves 5x better medical outcomes and lowers total costs by 40%. Paradigm accomplishes this by bringing together nationally recognized doctors, nurses and specialists, the best network of care facilities in the country, and 25 years of clinical data to guide decisions. For more information, visit www.paradigmcorp.com.